Correction to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand (PharmacoEconomics, (2019), 37, 2, (267-278), 10.1007/s40273-018-0736-0)

Bunchai ChongmelaxmePochamana PhisalprapaRatree ManthaisongPiyameth DilokthornsakulNathorn ChaiyakunaprukNaresuan UniversityMonash University MalaysiaFaculty of Medicine, Siriraj Hospital, Mahidol UniversityMahasarakham UniversityUniversity of Wisconsin2020-01-272020-01-272019-02-13PharmacoEconomics. Vol.37, No.2 (2019), 29111792027117076902-s2.0-85060121046https://repository.li.mahidol.ac.th/handle/20.500.14594/51869© 2018, Springer Nature Switzerland AG. Weight Reduction is Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand.Mahidol UniversityMedicineCorrection to: Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-alcoholic Fatty Liver Disease in Thailand (PharmacoEconomics, (2019), 37, 2, (267-278), 10.1007/s40273-018-0736-0)ErratumSCOPUS10.1007/s40273-018-0754-y